Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

Asberg, A. et al. (2009) Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients. American Journal of Transplantation, 9(5), pp. 1205-1213.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jardine, Professor Alan
Authors: Asberg, A., Humar, A., Jardine, A., Rollag, H., Pescovitz, M., Mouas, H., Bignamini, A., Toz, H., Dittmer, I., Montejo, M., and Hartmann, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:American Journal of Transplantation
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1600-6135

University Staff: Request a correction | Enlighten Editors: Update this record